Nov 21, 2022

Scientists have just made a breakthrough for a potential glioblastoma drug

Posted by in categories: biotech/medical, neuroscience

People affected by the lethal glioblastoma cancer only live for 12–18 months after diagnosis.

A global trial that began in 2007 has confirmed that a vaccine for the treatment of the most lethal brain cancer can give patients years of extended life.

“This is a potent molecule that’s very exciting to us in terms of its potential for deployment against glioblastoma,” said Steve Kay, Ph.D., the senior author of the study.

Comments are closed.